UNCOMMON OBESITY | RHYTHM

Multiple Owners – DSA + DTC/HCP Integrated Campaign – Packaging – Launch

The challenge was clear: introduce IMCIVREE, as the first and only treatment targeting MC4R pathway impairment in the brain for patients with acquired hypothalamic obesity (HO). In less than a year, our team delivered a comprehensive market entry, encompassing the brand pitch, packaging design, a targeted DSA program, and an integrated campaign. Central to our strategy was the core insight that 'not all types of obesity are the same' a concept that redefined the brand narrative and served as the foundation for all communication efforts.